AlphaCrest Capital Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,902
Closed -$562K 1034
2022
Q3
$562K Sell
10,902
-2,119
-16% -$126K 0.03% 929
2022
Q2
$684K Buy
13,021
+6,704
+106% +$467K 0.03% 841
2022
Q1
$543K Sell
6,317
-10,892
-63% -$895K 0.03% 861
2021
Q4
$1.41M Buy
17,209
+8,060
+88% +$589K 0.05% 628
2021
Q3
$608K Sell
9,149
-25,754
-74% -$1.83M 0.03% 835
2021
Q2
$2.34M Buy
34,903
+22,294
+177% +$1.38M 0.1% 304
2021
Q1
$656K Buy
12,609
+2,143
+20% +$108K 0.04% 674
2020
Q4
$418K Sell
10,466
-14,242
-58% -$460K 0.03% 756
2020
Q3
$606K Buy
+24,708
New +$631K 0.07% 479
2020
Q2
Sell
-34,757
Closed -$501K 1116
2020
Q1
$501K Buy
34,757
+23,739
+215% +$681K 0.06% 570
2019
Q4
$419K Sell
11,018
-9,730
-47% -$291K 0.03% 894
2019
Q3
$459K Buy
+20,748
New +$442K 0.03% 952
2019
Q2
Sell
-33,000
Closed -$952K 1133
2019
Q1
$952K Buy
33,000
+15,800
+92% +$390K 0.14% 203
2018
Q4
$295K Buy
+17,200
New +$416K 0.09% 459

Other funds holding THC

AlphaCrest Capital Management's THC Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Tenet Healthcare (THC) in Q4 2022, closing a stake of 10,902 shares — an estimated $562K sold.

AlphaCrest Capital Management first reported a position in THC in Q4 2018 and held it in 14 quarters. The position peaked at $2.34M in Q2 2021. 355 funds tracked by Wall St. Rank hold THC as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Tenet Healthcare position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 10,902 Tenet Healthcare shares in Q4 2022, an estimated $562K.
  • AlphaCrest Capital Management first reported a position in Tenet Healthcare in Q4 2018 and held it in 14 quarters.
  • AlphaCrest Capital Management's Tenet Healthcare position peaked at $2.34M in Q2 2021.
  • 355 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.